Background: There is a large mortality gap between patients with a nonaffective psychotic disorder and those in the general population, is associated with both natural and nonnatural death causes.

Objective: This study aims to assess whether mortality risks vary for different causes of death according to the duration since diagnosis and age in a large sample of patients with nonaffective psychotic disorder.

Methods: Data of patients with nonaffective psychotic disorder (n = 12,580) from 3 Dutch psychiatric registers were linked to the cause of death register of Statistics Netherlands and compared with personally matched controls (n = 124,143) from the population register. Death rates were analyzed by duration since the date of the registered diagnosis of the (matched) patient and their age using a Poisson model.

Results: Among patients, the rates of all-cause death decreased with longer illness duration. This was explained by lower suicide rates. For example, among those between 40 and 60 years of age, the rate ratios (RR) of suicide during 2-5 and > 5 years were 0.52 and 0.46 (p = 0.002), respectively, when compared with the early years after diagnosis. Compared with controls, patients experienced higher rates of natural death causes during all stages and in all age categories, rate ratios 2.35-5.04; p < 0.001-0.025. There was no increase in these rate ratios with increasing duration or increasing age for patients when compared with controls.

Conclusions: The high risk of natural death causes among patients with nonaffective psychotic disorder is already present at a comparatively young age. This suggests caution in blaming antipsychotics or the accumulating effects of adverse lifestyle factors for premature death. It is better to proactively monitor and treat somatic problems from the earliest disease stages onward.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psym.2013.05.011DOI Listing

Publication Analysis

Top Keywords

patients nonaffective
16
nonaffective psychotic
16
psychotic disorder
12
rate ratios
12
patients
8
illness duration
8
death
8
natural death
8
age
7
duration
5

Similar Publications

Background: This study evaluated the prevalence of various mental disorders and their influence on mortality outcomes in individuals with cancer.

Methods: The authors' institutional database included patients with cancer diagnosed between 2011 and 2015 who had mental disorders and death information up to 2021. Mental disorders included nonaffective psychotic disorders, affective psychotic disorders, anxiety-related and stress-related disorders, alcohol or drug misuse, and mood disorders without psychotic symptoms.

View Article and Find Full Text PDF

Bipolar disorder is a chronic disease that imposes a lifelong burden on those that suffer from it. Lithium is still considered both gold standard treatment and first-line maintenance treatment, and access to treatment with lithium is paramount to improving patient outcomes. However, access to adequate treatment is not only contingent on symptom recognition, accurate diagnosis, and individualization of treatment, but also affected by racial and ethnic disparities at each stage of patient experience.

View Article and Find Full Text PDF

Stress is a key factor in psychotic relapse, and mindfulness offers stress resilience and well-being benefits. This study examined the effects of mindfulness-based intervention for psychosis (MBI-p) in preventing relapse at 1 year among patients with remitted psychosis in Hong Kong. MBI-p is a newly developed manual-based mindfulness protocol and was tested to have improved well-being and clinical outcomes in a pilot study with remitted psychosis patients.

View Article and Find Full Text PDF

Electroconvulsive therapy use in New South Wales between 1944 and 1949.

Australas Psychiatry

December 2024

Discipline of Psychiatry and Mental Health, University of NSW, Sydney, AU -NSW, Australia.

Aims: To identify clinical and other factors associated with the use of electroconvulsive therapy (ECT) in New South Wales for the period 1944-1949 and to compare with contemporaneous practice.

Method: Annual reports of the Inspector-General of Mental Hospitals in NSW (1944/45 to 1948/49) were examined.

Main Findings: Seven hospitals reported a total of 8964 courses of treatment during the period.

View Article and Find Full Text PDF

Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study.

Psychiatry Res

December 2024

Department of Psychiatry, Navarra University Hospital, Pamplona, Spain; Mental Health Department, Navarra Health Service - Osasunbidea, Pamplona, Spain. Electronic address:

The predictors of clinical evolution after nonaffective first-episode psychosis (NAFEP) have yet to be fully elucidated. It is important to weigh the long-term benefits of maintained antipsychotic (AP) treatment against the risks of relapse upon discontinuation. Between January 2017 and December 2022, we recruited 211 NAFEP patients from the Programa de Primeros Episodios Psicóticos de Navarra (PEPsNa) who achieved clinical remission within two years and continued follow-up.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!